More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia
ATC Code: C09AA01
Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aldosterone low | x | ||||||||||||||||||
| Angioedema | x | x | x | x | x | ||||||||||||||
| Cardiac failure | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Cardiac failure congestive | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Cardiac output increased | x | ||||||||||||||||||
| Cerebrovascular accident | x | ||||||||||||||||||
| Collagen-vascular disease | x | x | x | x | x | x | x | ||||||||||||
| Diabetes mellitus | x | ||||||||||||||||||
| Diabetic nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Fluid loss | x | ||||||||||||||||||
| Hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Hypertensive | x | ||||||||||||||||||
| Hypotensive | x | x | |||||||||||||||||
| Infarction | x | x | |||||||||||||||||
| Left ventricular dysfunction | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Malignant hypertension | x | x | x | ||||||||||||||||
| Microalbuminuria | x | ||||||||||||||||||
| Myocardial infarction | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Nephropathy | x | x | |||||||||||||||||
| Postinfarction | x | ||||||||||||||||||
| Proteinuria | x | x | x | x | x | x | |||||||||||||
| Rash | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Renal impairment | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Renin decreased | x | ||||||||||||||||||
| Retinal disorder | x | x | x | x | x | x | x | ||||||||||||
| Serum potassium increased | x | ||||||||||||||||||
| Type 1 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Type 2 diabetes mellitus | x | ||||||||||||||||||
| Vascular resistance | x | ||||||||||||||||||
| Vascular resistance systemic | x | ||||||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |